Compare your options
Compare Zepbound, Mounjaro, Wegovy and Ozempic side by side — active ingredient, dosing and monthly pricing through PrimeVida.
Brand-name weight-loss injection
Zepbound is brand-name tirzepatide approved for chronic weight management in eligible patients. It acts on GIP and GLP-1 pathways to reduce calorie intake and help you feel satisfied longer, giving you stronger support for losing weight and keeping it off.
Brand-name tirzepatide
Mounjaro is brand-name tirzepatide, a once-weekly GIP/GLP-1 medication approved to improve blood sugar control in people with type 2 diabetes. It combines two incretin pathways in one treatment and is prescribed when your clinician determines the branded medication fits your medical needs.
Brand-name semaglutide
Wegovy is brand-name semaglutide approved for chronic weight management in eligible patients. It works through the GLP-1 pathway to help regulate appetite and calorie intake, making it easier to stay consistent with the habits that support long-term weight loss.
Brand-name semaglutide
Ozempic is a once-weekly brand-name semaglutide injection approved to improve blood sugar control in adults with type 2 diabetes. It works through the GLP-1 pathway and is prescribed when your clinician determines it is the right branded treatment for your metabolic health needs.
Semaglutide and tirzepatide are available as injectable or sublingual RDT protocols, often at a lower monthly cost than brand medications.